Your browser doesn't support javascript.
loading
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.
Marczyk, M; Mrukwa, A; Yau, C; Wolf, D; Chen, Y-Y; Balassanian, R; Nanda, R; Parker, B A; Krings, G; Sattar, H; Zeck, J C; Albain, K S; Boughey, J C; Liu, M C; Elias, A D; Clark, A S; Venters, S J; Shad, S; Basu, A; Asare, S M; Buxton, M; Asare, A L; Rugo, H S; Perlmutter, J; DeMichele, A M; Yee, D; Berry, D A; Veer, L Van't; Symmans, W F; Esserman, L; Pusztai, L.
Afiliación
  • Marczyk M; Department of Data Mining and Engineering, Silesian University of Technology, Gliwice, Poland; Department of Breast Medical Oncology, Yale School of Medicine, New Haven, USA.
  • Mrukwa A; Department of Data Mining and Engineering, Silesian University of Technology, Gliwice, Poland.
  • Yau C; Departments of Surgery, University of California, San Francisco, USA.
  • Wolf D; Departments of Surgery, University of California, San Francisco, USA; Departments of Laboratory Medicine, University of California, San Francisco, USA.
  • Chen YY; Departments of Pathology, University of California, San Francisco, USA.
  • Balassanian R; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA.
  • Nanda R; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, USA.
  • Parker BA; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, USA.
  • Krings G; Departments of Surgery, University of California, San Francisco, USA.
  • Sattar H; Department of Pathology, University of Chicago, Chicago, USA.
  • Zeck JC; Department of Pathology, Georgetown University, Washington, USA.
  • Albain KS; Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, USA.
  • Boughey JC; Departments of Surgery, Mayo Clinic, Rochester, USA.
  • Liu MC; Departments of Oncology, Mayo Clinic, Rochester, USA.
  • Elias AD; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Center, Aurora, USA.
  • Clark AS; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, USA.
  • Venters SJ; Departments of Laboratory Medicine, University of California, San Francisco, USA.
  • Shad S; Departments of Surgery, University of California, San Francisco, USA.
  • Basu A; Departments of Surgery, University of California, San Francisco, USA.
  • Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, USA.
  • Buxton M; Departments of Surgery, University of California, San Francisco, USA.
  • Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, USA.
  • Rugo HS; Department of Medicine, Division of Hematology-Oncology, University of California, San Francisco, USA.
  • Perlmutter J; Gemini Group, Ann Arbor, USA.
  • DeMichele AM; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, USA.
  • Yee D; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, USA.
  • Berry DA; Berry Consultants, LLC, Houston, USA.
  • Veer LV; Departments of Laboratory Medicine, University of California, San Francisco, USA.
  • Symmans WF; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Esserman L; Departments of Surgery, University of California, San Francisco, USA.
  • Pusztai L; Department of Breast Medical Oncology, Yale School of Medicine, New Haven, USA. Electronic address: lajos.pusztai@yale.edu.
Ann Oncol ; 33(8): 814-823, 2022 08.
Article en En | MEDLINE | ID: mdl-35513244
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos